TriangleNCT00007345 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- 7 cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.
- point Of Contact
- DunleavK@mail.nih.gov
- organization
- National Cancer Institute
- phone
- 301-435-1007
- title
- Dr. Kieron Dunleavy
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- 7 cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.
- point Of Contact
- DunleavK@mail.nih.gov
- organization
- National Cancer Institute
- phone
- 301-435-1007
- title
- Dr. Kieron Dunleavy
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice